After a median follow-up of 207 months ( IQR 142-254 ) , median overall survival was 314 months ( 95 % CI 286-not estimable ) with orteronel plus prednisone and 295 months ( 270-not estimable ) with placebo plus prednisone ( HR 092 , 95 % CI 079-108 ; p = 031 ) .